Navigation Links
Martek Announces Fourth Quarter and FY 2007 Financial Results
Date:12/12/2007

r to the higher regional court

in Dusseldorf.

-- Martek Obtains Permanent Injunction Against Lonza in U.S. Patent

Infringement Suit -- In November 2007, a judge in the United States

District Court in Delaware ruled on various post-trial motions and

entered a permanent injunction in Martek's favor against the

defendants in Martek's patent infringement suit against Lonza Ltd.,

Nutrinova Inc. and Nutrinova Nutrition Specialties & Food

Ingredients GmbH. The judge upheld the October 2006 jury verdict

that the defendants infringed all of the asserted claims of two of

Martek's patents and that these patents were valid, and the judge

granted a permanent injunction with respect to these two patents.

Martek expects the defendant will appeal this decision, and the

permanent injunction will be in effect pending any appeal. With

respect to a third patent, the judge reversed the jury verdict;

however, Martek does not believe this will have an adverse effect on

the strength of the permanent injunction and is considering

alternatives regarding this patent. Martek plans to appeal the

judge's ruling on the third patent.

-- European Patent Office Upholds DHA Food Patent -- In November 2007,

the Opposition Division of the European Patent Office (EPO) upheld

one of the Company's European DHA patents. The modified claims of

the patent are narrower than the claims originally granted but

broader than the claims that were previously upheld in a December

2000 Opposition Division hearing. The patent, which expires in

November 2010, relates to fermentation processes, human and animal

food products, pharmaceutical uses of certain claimed microorganisms

and Martek's food DHA pro
'/>"/>

SOURCE Martek Biosciences Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Martek to Announce Third Quarter 2007 Results on September 5, 2007
2. Martek to Present at Upcoming UBS Conference
3. Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
4. Martek Announces Settlement of OmegaTech Milestone Litigation
5. Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge
6. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
7. Martek to Present at Upcoming ThinkEquity Partners Conference
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... The next implants made from the PEEK-OPTIMA® ... (European) approval. The CE mark is necessary for distributing ... the European Union. Following the Class IIb approval route, ... supplied by the Turkey-based company Osimplant for the treatment ... Expandable Bladed HA PEEK Cage line of spinal implants, ...
(Date:3/4/2015)... -- Brooklyn residents now have a new place to go ... Nunzio Saulle , M.D., a board-certified physiatrist, is ... Physical Medicine and Rehabilitation (PM&R) practice in ... Health Plus Management, LLC is managing the day-to-day operations ... Avenue. This new PM&R practice will treat patients suffering ...
(Date:3/4/2015)... March 04, 2015 PRC Clinical, ... the San Francisco Bay Area, will exhibit and present ... Conference 2015 on March 25th and 26th in ... build relationships with Israeli life science companies seeking to ... The company’s services span all phases of human trials, ...
(Date:3/4/2015)... 2015 Follow us on LinkedIn ... the fastest growing technologies in the life sciences industry. ... is driving growth in nucleic acid detection technologies like ... gene expressions will continue to benefit the qPCR and ... ranging from pharma, biotech, food & beverage to animal ...
Breaking Biology Technology:Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 2Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 3NJS Physical Medicine & Rehabilitation Opening on Flatbush Avenue, Brooklyn, NY 2PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 2PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 3PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 4Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 2Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 4
... Mount Sinai School of Medicine received a contract for ... (NIH) and the National Heart and Lung Institute (NHLBI) ... contract is one of four issued nationally to develop ... tools for diagnosing and treating heart, lung and blood ...
... Generex Biotechnology Corporation (Nasdaq: GNBT ), which ... drug delivery systems and technologies, today announced that its ... President and Chief Executive Officer effective immediately. The Board ... serve as Chairman of the Board. Mr. ...
... The Wireless-Life Sciences Alliance (WLSA) announced today a ... upcoming Wireless Health 2010 conference, where researchers from ... Edinburgh, UCLA, and the University of Virginia, will ... wireless health technologies with thought leaders from academia, ...
Cached Biology Technology:Mount Sinai leads program of excellence in nanotechnology with $16.5 million grant 2Mount Sinai leads program of excellence in nanotechnology with $16.5 million grant 3Generex Biotechnology Appoints Mark Fletcher as Interim President and CEO, and John P. Barratt as Chairman of the Board 2Generex Biotechnology Appoints Mark Fletcher as Interim President and CEO, and John P. Barratt as Chairman of the Board 3Wireless Health 2010 Explores the Roles of Wireless Technologies in Clinical Services 2Wireless Health 2010 Explores the Roles of Wireless Technologies in Clinical Services 3
(Date:2/5/2015)... Calif. , Jan. 27, 2015 /PRNewswire/ ... provider of globally deployed, innovative test solutions ... announced the delivery of its TS-323 ... Space Systems Company (LMSSC). GENASYS is a ... demands of mission-critical applications that require performance ...
(Date:2/5/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/6lngtl/global_biometrics ) ... Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, ... their offering. , In global ... anticipated to overtake North America ... towards IT security, government biometric based projects such ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... "Biometrics - A Global Market Overview" report to their ... technology is to ensure that an individual is who she/he ... may make use of a person,s unique physical characteristics, such ...
Breaking Biology News(10 mins):Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
... treatment for infertility give an increased risk of pre-eclampsia among pregnant ... Institute of Public Health. More than 20 000 first-time mothers from ... the study. Normal risk ... had a 5.2 % risk of pre-eclampsia. ...
... Biopharmacy and Nanomedicine, Department of Pharmaceutics and Analytical ... (approximately 3.75 million Euros) from the Danish Council ... for Pharmaceutical Nanotechnology and Nanotoxicology (CPNN) at the ... Prof. Moghimi will act as the Director ...
... Global warming, some have argued, can be reversed with ... blimp spray liquefied sulfur dioxide in the stratosphere or ... the atmosphere to filter out carbon dioxide. ... UCLA Department of Atmospheric and Oceanic Sciences and a ...
Cached Biology News:Miscarriage and infertility treatment increase pre-eclampsia risk 2Donation for new Center for Pharmaceutical Nanotechnology and Nanotoxicology 2No quick or easy technological fix for climate change, researchers say 2No quick or easy technological fix for climate change, researchers say 3No quick or easy technological fix for climate change, researchers say 4
... Bio-Stack Twister II Microplate Handler is ... solution for integrating BioTeks washers, readers ... expandable microplate capacity, ultimate flexibility and ... are adding capacity to single devices ...
... rapid analytical to medium scale affinity purification ... vectors. Sufficient reagents are provided for purification ... under native or denaturing conditions. Crude samples ... retains STag fusion proteins. After unbound proteins ...
... Biotech Solutions Group combines deep experience, skills ... qualities of collaborative team chemistry. This combination ... to approval and beyond.,With AAIBiotech, you can ... you get more than that: its the ...
S-100 alpha/beta chain (8B10)...
Biology Products: